Therapeutics
Molecular Targeting
Aptamers for Targeted Therapy Development
Jump To:
Overview
Aptamers are short, single-stranded DNA or RNA molecules that bind with high affinity and specificity to target molecules.
These versatile oligonucleotides can be engineered to recognize a wide range of targets, from small molecules to proteins and even whole cells, making them a valuable tool in therapeutic applications. However, aptamer synthesis requires precise control and expertise to ensure optimal binding affinity, specificity, and stability.
Oligo Factory leverages finely tuned solid phase synthetic chemistry to produce high-quality aptamers from microgram to hundreds of grams quantities. Our NANDA Series synthesizers enable precise control and enhanced purity for even the most complex aptamer sequences.
Features & Benefits
Use Cases
Facilitating Breakthroughs
Our high quality gRNA support successful CRISPR gene editing.
- Genome-wide screening for target identification
- Cancer immunotherapy research
- Infectious disease modeling and treatment
- Functional genomics studies
- Development of CRISPR-based gene therapies
